Back to search
FDAFDA · Food and drugs·Recall number D-499-2013

Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 54868-4814-0, MFG By TEVA Pharmaceuticals USA, Sellersville, PA

Published June 5, 2013 · Recall initiated: March 18, 2013

Summary

FDA records drug Class III recall D-499-2013, published June 5, 2013 and initiated March 18, 2013. Recalling firm: Physicians Total Care, Inc.; Status: Terminated; Reported quantity: 6 cards of 28 tablets; Lot: Physicians Total Care Lots: 6Z4C Exp. 10/31/2013. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

What to do

Voluntary: Firm initiated · FAX

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Physicians Total Care, Inc.
Distributor
MO
Lot
Physicians Total Care Lots: 6Z4C Exp. 10/31/2013
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 54868-4814-0, MFG By TEVA Pharmaceuticals USA, Sellersville, PA recalled?

Yes. FDA published recall D-499-2013 on June 5, 2013. Reported hazard: Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

What should I do if I have this product?

Voluntary: Firm initiated · FAX